C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2002
11/21/2002	WO2002092853A1 Detection of spore forming bacteria
11/21/2002	WO2002092851A2 Genetic typing
11/21/2002	WO2002092850A2 Diagnostic method for osteoporosis and related disorders
11/21/2002	WO2002092849A2 Methods
11/21/2002	WO2002092848A1 Oligonucleotide primers for detection of streptomyces species
11/21/2002	WO2002092847A2 Method for analysing dna of sweetpotato
11/21/2002	WO2002092846A1 Method of monitoring a fermentation process
11/21/2002	WO2002092845A2 Method for determining enzymatic activity of glycosyl transferase
11/21/2002	WO2002092844A1 Thermostable proteinases from thermophilic bacteria
11/21/2002	WO2002092843A1 Method of counting microbial cells
11/21/2002	WO2002092842A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092840A2 Agents that regulate apoptosis
11/21/2002	WO2002092838A2 Allelic variants of delta opioid receptors associated with disorders of feeding and energy homeostasis
11/21/2002	WO2002092837A2 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
11/21/2002	WO2002092836A2 Nucleic acid sequence encoding ovarian antigen, ca125, and uses thereof
11/21/2002	WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/21/2002	WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002	WO2002092825A2 Retroviral vectors for gene therapy
11/21/2002	WO2002092808A1 Random gene unidirectional antisense library
11/21/2002	WO2002092807A1 Unigene unidirectional antisense library
11/21/2002	WO2002092803A1 Phosphotriesterase from agrobacterium radiobacter p230
11/21/2002	WO2002092788A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092780A2 Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof
11/21/2002	WO2002092776A2 Methods for the indentification of inhibitors of 2-hydroxyisoflavone reductase expression or activity in plants
11/21/2002	WO2002092774A2 Replicase cycling reaction amplification
11/21/2002	WO2002092768A2 Novel alanine transaminase enzyme and methods of use
11/21/2002	WO2002092767A2 DETECTION OF GD2 SYNTHASE mRNA AND USES THEREOF
11/21/2002	WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002	WO2002092763A2 Intron associated with myotonic dystrophy type 2 and methods of use
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092615A2 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
11/21/2002	WO2002092612A2 Nucleic acids that bind to enterotoxin b
11/21/2002	WO2002092202A1 Method of treating filter membrane, filter membrane, and method of rapidly counting number of microorganism with the filter membrane
11/21/2002	WO2002092199A1 Detection of cells using molecular electrophoretic change
11/21/2002	WO2002092128A1 Compositions and methods to regulate serum phosphate
11/21/2002	WO2002092124A1 Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof
11/21/2002	WO2002092118A1 Global analysis of protein activities using proteome chips
11/21/2002	WO2002092116A1 Targeted delivery of drugs for the treatment of viral infections
11/21/2002	WO2002092015A2 Reagents and methods for modulating dkk-mediated interactions
11/21/2002	WO2002092013A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	WO2002092009A2 A method of characterizing a homeopathic preparation
11/21/2002	WO2002092007A2 Screening methods for pathogen virulence factors under low oxygen conditions.
11/21/2002	WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002	WO2002092002A2 Screening, diagnostic and therapeutic methods relating to riz
11/21/2002	WO2002092000A2 Hbm variants that modulate bone mass and lipid levels
11/21/2002	WO2002091820A1 Nonhuman model animal of oligodendrocyte development disability
11/21/2002	WO2002082432A8 Isolated genome of xyllela fastidiosa and uses thereof
11/21/2002	WO2002081752A3 Methods and kits useful for the simplification of complex peptide mixtures
11/21/2002	WO2002077211A8 A virus (cryptovirus) within the rubulavirus genus and uses therefor
11/21/2002	WO2002074981A3 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
11/21/2002	WO2002074949A9 Preparation of calibrants and use thereof in the quantification of nucleotide sequences of interest
11/21/2002	WO2002072878A3 Method for forgery-proof marking; forgery-proof marking and kit
11/21/2002	WO2002060340A9 Method for identifying maxi-k channel blockers
11/21/2002	WO2002059604A8 Diagnosis and treatment of multiple sclerosis
11/21/2002	WO2002058532A3 Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof
11/21/2002	WO2002055720A3 Materials and methods relating to protein aggregation in neurodegenerative disease
11/21/2002	WO2002046381A3 Method for the prevention or reduction of haze in beverages
11/21/2002	WO2002037106A3 Methods for comparitive analysis of carbohydrate polymers
11/21/2002	WO2002031201A3 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
11/21/2002	WO2002018637A3 Diagnosis and treatment of prostate cancer
11/21/2002	WO2002018630A3 Method of establishing resistance profiles of tissues and cell lines
11/21/2002	WO2002014467A3 Cng2b: a putative human cyclic nucleotide-gated ion channel
11/21/2002	WO2002004957A3 Fourier transform mass spectrometry of complex biological samples
11/21/2002	WO2002000926A3 Diagnosis of diseases associated with signal transduction
11/21/2002	WO2002000730A3 Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/21/2002	WO2001087350A3 Treatment of human papillomavirus (hpv)-infected cells
11/21/2002	WO2001080876A8 Utilization of adamts-1 protein and method of screening aggrecanase activity regulator
11/21/2002	WO2001042273A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/21/2002	WO2001023886A9 Improved toxicity screening method
11/21/2002	WO2001019844A9 Altered nucleotide sequence in cd40 ligand promotor
11/21/2002	WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002	US20020174447 Performing matings between first parent strain carrying mutation in Alzheimer's disease gene and a series of parent strains each containing one of a series of genetic variations to produce a series of test progeny, screening
11/21/2002	US20020174446 Identification of genes involved in alzheimer's disease using drosophila melanogaster
11/21/2002	US20020174096 Interactive correlation of compound information and genomic information
11/21/2002	US20020173638 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
11/21/2002	US20020173626 Fusion protein for use in the diagnosis, prevention and treatment of liver disorders
11/21/2002	US20020173624 Polypeptide for use in treatment and prevention of liver, nervous system and glandular disorders
11/21/2002	US20020173480 Polynucleotides; analyzing binding between detector and target
11/21/2002	US20020173469 Protease inhibitors
11/21/2002	US20020173464 Modulation of pericyte proliferation
11/21/2002	US20020173463 Isolated nucleic acids; and antibodies
11/21/2002	US20020173461 Methods for enhancing the efficacy of cancer therapy
11/21/2002	US20020173458 Polypeptides; genetic engineering
11/21/2002	US20020173457 Polypeptides
11/21/2002	US20020173454 Nucleic acids, proteins, and antibodies
11/21/2002	US20020173445 Selective androgen receptor modulators and methods for their identification, design and use
11/21/2002	US20020173048 Apparatus for use in the analysis of preferential nucleotide sequences
11/21/2002	US20020173045 Method for determining the size of a spherical or elipsoidal molecule
11/21/2002	US20020173039 Packaging systems for human recombinant adenovirus to be used in gene therapy
11/21/2002	US20020173022 Polypeptide for use in the diagnosis, prevention and treatment of inflammation and disorders associated with cell proliferation and apoptosis
11/21/2002	US20020173016 High-throughput nucleic acid polymerase devices and methods for their use
11/21/2002	US20020173007 Human chemokine polypeptides
11/21/2002	US20020173005 Nucleotide sequences coding polypeptide for use in the treatment of thrombosis
11/21/2002	US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002	US20020172997 Replication of preefrential nucleotide sequences; obtain nucleotide sequences, insert into vector, incubate with recombinase, recover vector, amplify nucleotide sequences
11/21/2002	US20020172993 Synergistic nutrient broth for screening phosphate solubility in microorganisms
11/21/2002	US20020172992 Method for the determination of glycated hemoglobin
11/21/2002	US20020172991 Methods and kits for detecting protein kinases

1 ... 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 ... 3003